Høglund R, Bremel R, Homan E, Torsetnes S, Lossius A, Holmøy T. CD4+ T Cells in the Blood of MS Patients Respond to Predicted Epitopes From B cell Receptors Found in Spinal Fluid. Front Immunol. 2020;11:598 pubmed publisher

Cooley L, Martin R, Zellner H, Irani A, Uram Tuculescu C, El Shikh M, et al. Increased B Cell ADAM10 in Allergic Patients and Th2 Prone Mice. PLoS ONE. 2015;10:e0124331 pubmed publisher

Bankert K, Oxley K, Smith S, Graham J, de Boer M, Thewissen M, et al. Induction of an altered CD40 signaling complex by an antagonistic human monoclonal antibody to CD40. J Immunol. 2015;194:4319-27 pubmed publisher

Okimura K, Maeta K, Kobayashi N, Goto M, Kano N, Ishihara T, et al. Characterization of ASKP1240, a fully human antibody targeting human CD40 with potent immunosuppressive effects. Am J Transplant. 2014;14:1290-9 pubmed publisher

Frentsch M, Stark R, Matzmohr N, Meier S, Durlanik S, Schulz A, et al. CD40L expression permits CD8+ T cells to execute immunologic helper functions. Blood. 2013;122:405-12 pubmed publisher

Dumas G, Dufresne M, Asselin E, Girouard J, Carrier C, Reyes Moreno C. CD40 pathway activation reveals dual function for macrophages in human endometrial cancer cell survival and invasion. Cancer Immunol Immunother. 2013;62:273-83 pubmed publisher

Price A, Tourigny J, Forte E, Salinas R, Dave S, Luftig M. Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-?B activation. J Virol. 2012;86:11096-106 pubmed publisher

D Souza B, Edelstein L, Pegman P, Smith S, Loughran S, Clarke A, et al. Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor. J Virol. 2004;78:1800-16 pubmed

Francisco J, Donaldson K, Chace D, Siegall C, Wahl A. Agonistic properties and in vivo antitumor activity of the anti-CD40 antibody SGN-14. Cancer Res. 2000;60:3225-31 pubmed